Dietetics News
REAL News for RDs
Saturday, October 24, 2026 · UTC
Dietetics News
The Evidence

Study analyses alcohol consumption and body fat distribution in Oxford Biobank cohort

Published 14 October 2026, the paper arrives alongside multiple new registered clinical trials for obesity and metabolic health.

Sarah Lindqvist-Park
Clinical Nutrition Writer
Share on X
Stands on 6 placed sources from 3 publishers and 1 first-party instrument reading.
Scientists study link between alcohol and body fat distribution
Scientists study link between alcohol and body fat distribution AI illustrationhow this picture was made
A study examining alcohol consumption and body fat distribution was published 2026-10-14 in the International Journal of Obesity. Researchers analysed 5761 participants from the Oxford Biobank.[1] Concordia University researchers also published a 2026 study in Obesity Surgery examining pre-bariatric surgery patient diets and cardiometabolic health.[2] The ATTAIN-1 study focused on overweight or obese participants without diabetes. ATTAIN-2 included participants with type 2 diabetes. For both studies, obesity was defined as a BMI of 30 or higher and overweight as a BMI of 27 or higher.[3] As of 2026-10-14, PubMed and ClinicalTrials.gov list ten new or updated interventional and observational trials registered for obesity, overweight and related metabolic conditions. These include trials evaluating energy restricted diets, behavioural weight loss treatment, semaglutide, survodutide, nutrient sequencing and bariatric surgery outcomes. Trial sponsors include academic institutions and industry researchers.[4] [5] [6]
Proof6 sources · 4 publishers · signed
What this stands on
  1. A study published 2026-10-14 in the International Journal of Obesity analyzed 5761 participants from the Oxford Biobank to examine alcohol consumption and body fat distribution. · El Tiempo
  2. Concordia University researchers published a 2026 study in Obesity Surgery examining pre-bariatric surgery patient diets and cardiometabolic health. · Medical Xpress
  3. The ATTAIN-1 study focused on overweight or obese participants without diabetes, while ATTAIN-2 included participants with type 2 diabetes, with obesity defined as a BMI of 30 or higher and overweight as a BMI of 27 or higher. · Healthline Media
  4. "Effects of a 12-Week Individualized Energy-Restricted Diet on Perceived Stress and Serum Cortisol in Adults With Overweight or Obesity" newly registered on ClinicalTrials.gov (NCT07873762, first posted 2026-10-14) as an interventional trial for Obesity & Overweight. Design: single group. Sample: 30 (actual), ages 18 to 49. Runs 2020-07-01 to 2022-10-01 (about 27 months to the primary endpoint). Primary outcome: Change in Serum Cortisol Level at Baseline and Week 12; Change in Perceived Stress S · PubMed and ClinicalTrials.gov, read by the New studies instrument · the fact recordUnited Statesofficial source
  5. "GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes" newly registered on ClinicalTrials.gov (NCT07858864, first posted 2026-10-05) as an observational study for Obesity, Sarcopenia. Sample: 42 (estimated), ages 18. Runs 2026-05-30 to 2026-11-30 (about 6 months to the primary endpoint). Primary outcome: Change in SARC-F (Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls) total score at Baseline (GLP-1 RA initiation) and 3 months. Intervention · PubMed and ClinicalTrials.gov, read by the New studies instrument · the fact recordUnited Statesofficial source
  6. "Body Mass Index and Outcomes of Ultrasound-Guided Infraclavicular Brachial Plexus Block" newly registered on ClinicalTrials.gov (NCT07871994, first posted 2026-10-13) as an observational study for Obesity (BMI>30). Sample: 100 (estimated), ages 18. Runs 2026-10-15 to 2027-04-01 (about 6 months to the primary endpoint). Primary outcome: Infraclavicular Block Performance Time at During the preoperative block procedure on the day of surgery, from first block needle insertion to completion of local · PubMed and ClinicalTrials.gov, read by the New studies instrument · the fact recordUnited Statesofficial source
Part of this reads PubMed and ClinicalTrials.gov, the public registries of published studies and registered trials directly. We could not place any of them by their address. None of the publishers is an official body: that part stands on reporting, not on the underlying document or transcript.